Quick Takeaways
- Eliot Forster has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $12,075.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Eliot Forster
- Location
- Carmiel
- Summary
- The estimated net worth of Eliot Forster is at least $12,075 dollars as of 18 Mar 2026. Eliot Forster is the Director of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $12.1K.
- Signature
- /s/ Edward Sturchio, attorney-in-fact for Eliot Forster
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Eliot Forster and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Protalix BioTherapeutics, Inc. ($12,075).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Eliot Forster
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | Director | $12,075 | 03 Sep 2025 | ||
| FSTX | F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | 08 Mar 2023 | |||
| IMTX | Immatics N.V. | Director | 18 Mar 2026 |
Insider Transactions Reported by Eliot Forster:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.